Citation Impact
Citing Papers
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
2001 StandoutScienceNobel
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
2001 StandoutScienceNobel
A hexahistidine-Zn 2+ -dye label reveals STIM1 surface exposure
2007 StandoutNobel
Oxygen-regulated and Transactivating Domains in Endothelial PAS Protein 1: Comparison with Hypoxia-inducible Factor-1α
1999 StandoutNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy
1991
In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies
1994
Rac1 Activity Is Required for the Activation of Hypoxia-inducible Factor 1
2001 StandoutNobel
Complexity in simplicity: monogenic disorders and complex cardiomyopathies
1999
The Prospective Association of Serum Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-1 Levels with All Cause and Cardiovascular Disease Mortality in Older Adults: The Rancho Bernardo Study
2004
Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit
1997 StandoutNobel
The Failing Heart — An Engine Out of Fuel
2007 Standout
Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α
1997 StandoutNobel
Hypoxic Regulation of Lactate Dehydrogenase A
1995 StandoutNobel
Oxygen sensing and signaling: impact on the regulation of physiologically important genes
1999
Alterations in the creatine kinase system in the myocardium of cardiomyopathic hamsters
1989
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
1999 StandoutNatureNobel
Insulin-like Growth Factors and Subsequent Risk of Mortality in the United States
2007
In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease
1990
Animal Models of Heart Failure Recent Developments and Perspectives
1997
Nickel carcinogenesis
2003 Standout
Biochemical Characterization of the Epithelial Dystroglycan Complex
1999
Purification and Characterization of Hypoxia-inducible Factor 1
1995 StandoutNobel
Natriuretic Peptides
1998 Standout
Nickel essentiality, toxicity, and carcinogenicity
2002
The spectrum of diseases of small coronery arteries and their physiologic consequences
1990
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
2004 StandoutNatureNobel
Perspectives on Oxygen Sensing
1999 StandoutNobel
Regulation of the Erythropoietin Gene
1989
Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart
2002
The Role of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) in Hypoxic Induction of Gene Expression
1996 StandoutNobel
Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences
1995 StandoutNobel
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
1998 Standout
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Brain Creatine Kinase with Aging in F-344 Rats: Analysis by Saturation Transfer Magnetic Resonance Spectroscopy
1997
Homocysteine and Atherothrombosis
1998 Standout
Frailty in elderly people
2013 Standout
Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.
1995
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
1992
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies
1994
On the electrostatic properties of papain in relation to its enzymatic activity
1983
Genetic Models of Human Vascular Disease
1995 StandoutNobel
The preventive effect of verapamil on ethanol-induced cardiac depression: phosphorus-31 nuclear magnetic resonance and high-pressure liquid chromatographic studies of hamsters.
1987
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
1993 StandoutNobel
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
1995 StandoutNobel
The induction of tumours in the rat by a single oral dose of N-nitrosomethylurea.
1969
Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.
1981
Verapamil preserves myocardial performance and energy metabolism in left ventricular hypertrophy following ischemia and reperfusion. Phosphorus 31 magnetic resonance spectroscopy study.
1989
Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle
1977
Pungent products from garlic activate the sensory ion channel TRPA1
2005 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
1984 Standout
Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism.
1993 StandoutNobel
Regulation of the Erythropoietin Gene: Evidence That the Oxygen Sensor Is a Heme Protein
1988 Science
Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function.
1997
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Familial Hypertrophic Cardiomyopathy
1998
Subcellular basis of cardiac contractile failure
1978
Adenine nucleotide translocator in dilated cardiomyopathy: Pathophysiological alterations in expression and function
1997
Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice.
1991 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.
1994 StandoutNobel
Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.
1990
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
G PROTEIN–COUPLED RECEPTOR KINASES
1998 StandoutNobel
Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels
1983 StandoutNature
Electrostatic Basis for Enzyme Catalysis
2006 StandoutNobel
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene
2001
Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein
2001 StandoutNobel
DIRECT EVIDENCE FOR NEUROGENIC INFLAMMATION AND ITS PREVENTION BY DENERVATION AND BY PRETREATMENT WITH CAPSAICIN
1967
Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.
1991 StandoutNobel
Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene.
1991 StandoutNobel
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
1982 Standout
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.
1993 StandoutNobel
Creatine and Creatinine Metabolism
2000 Standout
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.
1980
Enalapril Treatment Increases Cardiac Performance and Energy Reserve Via the Creatine Kinase Reaction in Myocardium of Syrian Myopathic Hamsters With Advanced Heart Failure
1995
Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNase protection.
1990 StandoutNobel
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy
1997
Works of G. Jasmin being referenced
Studies of the mechanism of polycythemia induced in rats by Ni3S2.
1978
Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction
2000
Effect of Fasting, Phenobarbital, or Hydrocortisone on Serum Creatine-Phosphokinase And Aldolase Activity in Myopathic Syrian Hamsters
1975
[Polymyopathy and hereditary cardiomyopathy in the Syrian hamster. Selective inhibition of myocardial lesions].
1973
Hereditary polymyopathy and cardiomyopathy in the syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM‐X7.1 line
1982
Impairment of mitochondrial and sarcoplasmic reticular functions during the development of heart failure in cardiomyopathic (UM-X7.1) hamsters.
1986
Comparison of Heart Sarcolemmal Enzyme Activities in Normal and Cardiomyopathic (UM-X7.1) Hamsters
1976
[DISCUSSION ON THE NATURE OF RENAL TUMORS INDUCED IN THE RAT BY DIMETHYLNITROSAMINE].
1996
Polycythemia Induced in Rats by Intrarenal Injection of Nickel Sulfide Ni3S2
1975
Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy.
1986
Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters.
1988
CARDIOMYOPATHY OF HAMSTER DYSTROPHY
1979
Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex
1997
Myocardial Lesions in Strain 129 Dystrophic Mice
1962 Nature
Prevention of Myocardial Degeneration in Hamsters with Hereditary Cardiomyopathy
1980
ANF in experimental congestive heart failure.
1988
Dobutamine potentiates amrinone's beneficial effects in moderate but not in advanced heart failure. 31P-MRS in isolated hamster hearts.
1990
Membrane alteration in failing hearts of cardiomyopathic hamsters.
1975
Hereditary polymyopathy and cardiomyopathy in the syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function
1982
[The anaphylactoid inflammatory reaction; a study on the behavior of the transplanted shock organ].
1956
Renal carcinomas and erythrocytosis in rats following intrarenal injection of nickel subsulfide.
1976
Prevention of Hereditary Cardiomyopathy in the Hamster by Verapamil and Other Agents
1975
Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure.
1989
CARDIOMYOPATHY OF HAMSTER DYSTROPHY *
1979